Storgard Chris

Design Therapeutics, Inc. · Chief Medical Officer

Storgard Chris is listed in filings as Chief Medical Officer at Design Therapeutics, Inc.. This profile follows SEC Form 4 activity through Jan 5, 2026, including 2 public disclosures. Recent filings connect the profile to Design Therapeutics, Inc. (DSGN). The current snapshot covers public activity from May 23, 2025 to Jan 5, 2026. Reported amounts are shown as $1.9M to $2.3M. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.

Data sources and methodology

History Trades

CompanyValueActionPriceCurrent Price
Historical insider buys and sells before the latest disclosure date will appear here after more snapshots are available.